COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy.
Markus Weckmann, Thomas Bahmer, Jannie Marie Sand...
https://pubmed.ncbi.nlm.nih.gov/34326188/Actively Recruiting
Led by LungenClinic Grosshansdorf · Updated on 2023-10-12
400
Participants Needed
1
Research Sites
260 weeks
Total Duration
Researchers are studying adult asthma patients with varying severity, including mild to severe cases, both atopic and non-atopic, and with childhood or adult onset. This study also includes both smokers and non-smokers and collaborates with a pediatric cohort using similar procedures for data and biomaterial collection. The goal is to better understand asthmas different forms and underlying pathways to improve targeted treatment options. Participants are observed under a system biological approach that links clinical data, lung function tests, and biomaterials to define asthma phenotypes. The adult arm works alongside an equivalent pediatric cohort to explore questions about disease onset, exacerbation, and chronicity comprehensively. Participants will undergo clinical evaluations, lung function assessments, and biomaterial collection following standardized procedures. Researchers will monitor the data over two years to identify clinical asthma phenotypes. Participation involves regular assessments and data sharing, with a focus on safety and long-term understanding of asthma. The total participation duration covers the primary outcome measurement period of two years.
CONDITIONS
Adult Arm of DZL All Age Asthma Cohort (ALLIANCE)
T
Thomas J Bahmer, MD
J
Joern Bullwinkel, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
LungenClinic Grosshansdorf
Lead Sponsor
German Center for Lung Research
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 2 years
Participants undergo assessments to define clinical asthma phenotypes by combining clinical, lung function, and biomaterial data.
Duration - Up to 8 years
Participants are monitored over an extended period to observe asthma phenotypes and disease progression.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Markus Weckmann, Thomas Bahmer, Jannie Marie Sand...
https://pubmed.ncbi.nlm.nih.gov/34326188/Thomas Bahmer, Benjamin Waschki, Fee Schatz...
https://pubmed.ncbi.nlm.nih.gov/28052957/Nicole Maison, Jimmy Omony, Sabina Illi...
https://pubmed.ncbi.nlm.nih.gov/35210326/Lena Lagally, Lena Ullemeyer, Jimmy Omony...
https://pubmed.ncbi.nlm.nih.gov/42509549/Anika Habener, Ruth Grychtol, Svenja Gaedcke...
https://pubmed.ncbi.nlm.nih.gov/35595320/Sally E Wenzel
https://pubmed.ncbi.nlm.nih.gov/22561835/Oliver Fuchs, Thomas Bahmer, Markus Weckmann...
https://pubmed.ncbi.nlm.nih.gov/30126401/Sarah Rank Rønnow, Jannie Marie Bülow Sand, Line Mærsk Staunstrup...
https://pubmed.ncbi.nlm.nih.gov/35418159/Gary P Anderson
https://pubmed.ncbi.nlm.nih.gov/18805339/Olaf Holz, Benjamin Waschki, Henrik Watz...
https://pubmed.ncbi.nlm.nih.gov/33008938/LungenClinic Grosshansdorf
Lead Sponsor
German Center for Lung Research
Collaborating Sponsor